 |
Modified cholera toxin |
|---|---|
| Trade Name | |
| Orphan Indication | Gaucher disease |
| USA Market Approval | USA |
| USA Designation Date | 2017-02-07 00:00:00 |
| Sponsor | ERAD Therapeutics, Inc.;11500 Dahlia Terrace;Potomac, Maryland, 20854 |
| |
Modified cholera toxin |
|---|---|
| Trade Name | |
| Orphan Indication | Gaucher disease |
| USA Market Approval | USA |
| USA Designation Date | 2017-02-07 00:00:00 |
| Sponsor | ERAD Therapeutics, Inc.;11500 Dahlia Terrace;Potomac, Maryland, 20854 |